Digital Art Therapy for Young Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to determine whether a digital art therapy app can effectively help young adult cancer survivors improve their mental health. Participants will use the ARTCan App for six weeks, engaging in art therapy activities and tracking their mental health through weekly surveys. The study seeks to determine if this app is a feasible and acceptable way for individuals with mood issues to benefit from art therapy. Ideal candidates are young adults who have survived childhood cancer, experience mood issues, and are comfortable using technology for art and surveys. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance mental health support for cancer survivors.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on digital art therapy, so it's unlikely that medication changes are required.
What prior data suggests that the ARTCan App is safe for young adult cancer survivors?
In a previous study, researchers used the ARTCan Therapy App to offer digital art therapy to young cancer survivors. This app guided participants through a six-week program with weekly art activities. Research has shown that this method is well-received, with no reports of harm or safety issues. Art therapy is generally safe because it emphasizes creative expression rather than physical treatments. The digital nature of the ARTCan App enhances convenience and accessibility without introducing new risks. Overall, evidence suggests that this app safely supports the mental health of young cancer survivors through art therapy.12345
Why are researchers excited about this trial?
Digital art therapy via the ARTCan App is unique because it leverages technology to provide creative expression as a form of mental health support for young cancer survivors. Unlike traditional therapy sessions that require physical attendance, this app allows participants to engage in art therapy from anywhere, offering greater accessibility and convenience. Researchers are excited about this approach because it combines digital innovation with therapeutic art, potentially enhancing mental health outcomes by making therapy more engaging and tailored to individual needs.
What evidence suggests that the ARTCan App is effective for young cancer survivors?
Research has shown that digital art therapy, such as the ARTCan App, can improve mood and mental health in young adult cancer survivors. In this trial, participants will engage in art therapy through the ARTCan App for 6 weeks. The app provides a program that encourages creative expression, which is linked to emotional well-being. Users of similar digital art therapy tools have reported an improved quality of life, particularly in managing mood issues. The ARTCan App is a self-guided tool, making art therapy more accessible and allowing users to participate in activities at their convenience. Early evidence suggests this method can be a valuable support for young cancer survivors facing emotional challenges.12346
Who Is on the Research Team?
Soma Sengupta, MD
Principal Investigator
UNC Lineberger Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for young adult cancer survivors who have had a brain tumor or pediatric cancer. They should be interested in using digital art therapy and willing to complete weekly mental health surveys.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive digital art therapy via the ARTCan App for 6 weeks, with weekly art therapy prompts and mental health quality of life surveys
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ARTCan App
Find a Clinic Near You
Who Is Running the Clinical Trial?
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor
Ian's Friends Foundation
Collaborator